Pharmabiz48m
Qiagen introduces QIAcuityDx digital PCR system for clinical testing in oncology
Qiagen introduces QIAcuityDx digital PCR system for clinical testing in oncology: Venlo, the Netherlands Thursday, October 3, 2024, 14:00 Hrs [IST] Qiagen N.V., a Netherlands-base ...
Pharmabiz2h
Biocon Biologics refinances US$ 1.1 billion long term debt through US$ bonds and new syndicated facility
Biocon Biologics refinances US$ 1.1 billion long term debt through US$ bonds and new syndicated facility: Our Bureau, Bengaluru Thursday, October 3, 2024, 12:30 Hrs [IST] Biocon B ...
Pharmabiz2h
UNAIDS welcomes Gilead’s voluntary licensing agreements on HIV drug lenacapavir
UNAIDS welcomes Gilead’s voluntary licensing agreements on HIV drug lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 12:10 Hrs [IST] The Joint United Nations Progra ...
Pharmabiz2h
Gilead's licensing agreement for lenacapavir a move to preserve its monopoly, alleges TWN
Gilead's licensing agreement for lenacapavir a move to preserve its monopoly, alleges TWN: Our Bureau, New Delhi Thursday, October 3, 2024, 12:20 Hrs [IST] Third World Network (TW ...
Pharmabiz2h
Moderna doses first participant in phase 3 trial of mRNA norovirus vaccine, mRNA-1403
Moderna doses first participant in phase 3 trial of mRNA norovirus vaccine, mRNA-1403: Cambridge, Massachusetts Thursday, October 3, 2024, 12:00 Hrs [IST] Moderna, Inc, a global l ...
Pharmabiz2h
FIP publishes reference document on access to safe and quality essential medicines
FIP publishes reference document on access to safe and quality essential medicines: Our Bureau, Bengaluru Thursday, October 3, 2024, 12:45 Hrs [IST] International Pharmaceutical F ...
Pharmabiz3h
Eppendorf introduces CO2 incubator shaker, CellXpert CS220 on the market with integrated 180°C sterilization routine
Eppendorf introduces CO2 incubator shaker, CellXpert CS220 on the market with integrated 180°C sterilization routine: Hamburg, Germany Thursday, October 3, 2024, 11:00 Hrs [IST] ...
Pharmabiz3h
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...
Pharmabiz4h
Merck completes acquisition of investigational B-cell depletion therapy, CN201 from Curon Biopharma
Merck completes acquisition of investigational B-cell depletion therapy, CN201 from Curon Biopharma: Rahway, New Jersey Thursday, October 3, 2024, 10:00 Hrs [IST] Merck, known as ...
Pharmabiz5h
ERS Genomics, Université de Montréal ink CRISPR/Cas9 license agreement
ERS Genomics, Université de Montréal ink CRISPR/Cas9 license agreement: Dublin, Ireland Thursday, October 3, 2024, 09:00 Hrs [IST] ERS Genomics Limited (ERS), the CRISPR licensi ...
Pharmabiz6h
CSR offers a beacon of hope to address lacunae in Indian healthcare crises: Gauri Bahulkar
Nandita Vijayasimha, Bengaluru Thursday, October 3, 2024, 08:00 Hrs [IST] ...
Pharmabiz6h
NABL stresses on ethical practices in hiring, recruiting, and employing staff in laboratories
NABL stresses on ethical practices in hiring, recruiting, and employing staff in laboratories: Shardul Nautiyal, Mumbai Thursday, October 3, 2024, 08:00 Hrs [IST] The National Acc ...